BACKGROUND AND PURPOSE: CV following aneurysmal SAH is a significant cause of
morbidity and mortality. We review our experiences using PTA and IA verapamil infusion for …

BACKGROUND AND PURPOSE: Angioplasty and intra-arterial papaverine are promising
treatments for severe symptomatic vasospasm after subarachnoid hemorrhage (SAH), but …

BACKGROUND Transluminal balloon angioplasty (TBA) and intra-arterial papaverine (IAP)
appear to be valuable alternatives for the treatment of aneurysmal subarachnoid …

Cerebral vasospasm (CVS) is associated with delayed cerebral ischemia (DCI) after
aneurysmal subarachnoid hemorrhage (SAH). The most frequently used form of rescue …

✓ Cerebral vasospasm remains a major source of morbidity and death in patients with
aneurysmal subarachnoid hemorrhage (SAH). When vasospasm becomes refractory to …

Objectives To examine the clinical outcome of aneurysmal subarachnoid haemorrhage
(aSAH) patients exposed to cerebral vasospasm (CVS)-targeted treatments in a meta …

Cerebral vasospasm (CV) accounts significant morbimortality after aneurysmal
subarachnoid hemorrhage. The objective of this study was to compare the clinical outcome …

Objective Although endovascular therapy has been widely adopted for the treatment of
cerebral vasospasm after aneurysmal subarachnoid hemorrhage (aSAH), its effect on …

Current clinical practice standards are addressed for the invasive interventional
management of post-hemorrhagic cerebral vasospasm (PHCV) in patients with aneurysmal …

BACKGROUND: Cerebral vasospasm (VSP) is a major cause of morbidity and mortality
associated with subarachnoid hemorrhage. The current endovascular paradigm for VSP …